Nature Communications (Aug 2022)
Multiancestry exome sequencing reveals INHBE mutations associated with favorable fat distribution and protection from diabetes
- Parsa Akbari,
- Olukayode A. Sosina,
- Jonas Bovijn,
- Karl Landheer,
- Jonas B. Nielsen,
- Minhee Kim,
- Senem Aykul,
- Tanima De,
- Mary E. Haas,
- George Hindy,
- Nan Lin,
- Ian R. Dinsmore,
- Jonathan Z. Luo,
- Stefanie Hectors,
- Benjamin Geraghty,
- Mary Germino,
- Lampros Panagis,
- Prodromos Parasoglou,
- Johnathon R. Walls,
- Gabor Halasz,
- Gurinder S. Atwal,
- Regeneron Genetics Center,
- DiscovEHR Collaboration,
- Marcus Jones,
- Michelle G. LeBlanc,
- Christopher D. Still,
- David J. Carey,
- Alice Giontella,
- Marju Orho-Melander,
- Jaime Berumen,
- Pablo Kuri-Morales,
- Jesus Alegre-Díaz,
- Jason M. Torres,
- Jonathan R. Emberson,
- Rory Collins,
- Daniel J. Rader,
- Brian Zambrowicz,
- Andrew J. Murphy,
- Suganthi Balasubramanian,
- John D. Overton,
- Jeffrey G. Reid,
- Alan R. Shuldiner,
- Michael Cantor,
- Goncalo R. Abecasis,
- Manuel A. R. Ferreira,
- Mark W. Sleeman,
- Viktoria Gusarova,
- Judith Altarejos,
- Charles Harris,
- Aris N. Economides,
- Vincent Idone,
- Katia Karalis,
- Giusy Della Gatta,
- Tooraj Mirshahi,
- George D. Yancopoulos,
- Olle Melander,
- Jonathan Marchini,
- Roberto Tapia-Conyer,
- Adam E. Locke,
- Aris Baras,
- Niek Verweij,
- Luca A. Lotta
Affiliations
- Parsa Akbari
- Regeneron Genetics Center, Regeneron Pharmaceuticals Inc
- Olukayode A. Sosina
- Regeneron Genetics Center, Regeneron Pharmaceuticals Inc
- Jonas Bovijn
- Regeneron Genetics Center, Regeneron Pharmaceuticals Inc
- Karl Landheer
- Regeneron Pharmaceuticals Inc
- Jonas B. Nielsen
- Regeneron Genetics Center, Regeneron Pharmaceuticals Inc
- Minhee Kim
- Regeneron Genetics Center, Regeneron Pharmaceuticals Inc
- Senem Aykul
- Regeneron Genetics Center, Regeneron Pharmaceuticals Inc
- Tanima De
- Regeneron Genetics Center, Regeneron Pharmaceuticals Inc
- Mary E. Haas
- Regeneron Genetics Center, Regeneron Pharmaceuticals Inc
- George Hindy
- Regeneron Genetics Center, Regeneron Pharmaceuticals Inc
- Nan Lin
- Regeneron Genetics Center, Regeneron Pharmaceuticals Inc
- Ian R. Dinsmore
- Department of Molecular and Functional Genomics, Geisinger Health System
- Jonathan Z. Luo
- Department of Molecular and Functional Genomics, Geisinger Health System
- Stefanie Hectors
- Regeneron Pharmaceuticals Inc
- Benjamin Geraghty
- Regeneron Genetics Center, Regeneron Pharmaceuticals Inc
- Mary Germino
- Regeneron Pharmaceuticals Inc
- Lampros Panagis
- Regeneron Pharmaceuticals Inc
- Prodromos Parasoglou
- Regeneron Pharmaceuticals Inc
- Johnathon R. Walls
- Regeneron Pharmaceuticals Inc
- Gabor Halasz
- Regeneron Pharmaceuticals Inc
- Gurinder S. Atwal
- Regeneron Pharmaceuticals Inc
- Regeneron Genetics Center
- DiscovEHR Collaboration
- Marcus Jones
- Regeneron Genetics Center, Regeneron Pharmaceuticals Inc
- Michelle G. LeBlanc
- Regeneron Genetics Center, Regeneron Pharmaceuticals Inc
- Christopher D. Still
- Geisinger Obesity Institute, Geisinger Health System
- David J. Carey
- Geisinger Obesity Institute, Geisinger Health System
- Alice Giontella
- Department of Clinical Sciences Malmö, Lund University
- Marju Orho-Melander
- Department of Clinical Sciences Malmö, Lund University
- Jaime Berumen
- Unidad de Medicina Experimental de la Facultad de Medicina de la Universidad Nacional Autónoma de México
- Pablo Kuri-Morales
- Unidad de Medicina Experimental de la Facultad de Medicina de la Universidad Nacional Autónoma de México
- Jesus Alegre-Díaz
- Unidad de Medicina Experimental de la Facultad de Medicina de la Universidad Nacional Autónoma de México
- Jason M. Torres
- MRC Population Health Research Unit, Nuffield Department of Population Health, University of Oxford
- Jonathan R. Emberson
- MRC Population Health Research Unit, Nuffield Department of Population Health, University of Oxford
- Rory Collins
- Clinical Trial Service Unit & Epidemiological Studies Unit Nuffield Department of Population Health, University of Oxford
- Daniel J. Rader
- Department of Genetics, Perelman School of Medicine, University of Pennsylvania
- Brian Zambrowicz
- Regeneron Pharmaceuticals Inc
- Andrew J. Murphy
- Regeneron Pharmaceuticals Inc
- Suganthi Balasubramanian
- Regeneron Genetics Center, Regeneron Pharmaceuticals Inc
- John D. Overton
- Regeneron Genetics Center, Regeneron Pharmaceuticals Inc
- Jeffrey G. Reid
- Regeneron Genetics Center, Regeneron Pharmaceuticals Inc
- Alan R. Shuldiner
- Regeneron Genetics Center, Regeneron Pharmaceuticals Inc
- Michael Cantor
- Regeneron Genetics Center, Regeneron Pharmaceuticals Inc
- Goncalo R. Abecasis
- Regeneron Genetics Center, Regeneron Pharmaceuticals Inc
- Manuel A. R. Ferreira
- Regeneron Genetics Center, Regeneron Pharmaceuticals Inc
- Mark W. Sleeman
- Regeneron Pharmaceuticals Inc
- Viktoria Gusarova
- Regeneron Pharmaceuticals Inc
- Judith Altarejos
- Regeneron Pharmaceuticals Inc
- Charles Harris
- Regeneron Pharmaceuticals Inc
- Aris N. Economides
- Regeneron Genetics Center, Regeneron Pharmaceuticals Inc
- Vincent Idone
- Regeneron Pharmaceuticals Inc
- Katia Karalis
- Regeneron Genetics Center, Regeneron Pharmaceuticals Inc
- Giusy Della Gatta
- Regeneron Genetics Center, Regeneron Pharmaceuticals Inc
- Tooraj Mirshahi
- Geisinger Obesity Institute, Geisinger Health System
- George D. Yancopoulos
- Regeneron Pharmaceuticals Inc
- Olle Melander
- Department of Clinical Sciences Malmö, Lund University
- Jonathan Marchini
- Regeneron Genetics Center, Regeneron Pharmaceuticals Inc
- Roberto Tapia-Conyer
- Instituto Tecnológico y de Estudios Superiores de Monterrey
- Adam E. Locke
- Regeneron Genetics Center, Regeneron Pharmaceuticals Inc
- Aris Baras
- Regeneron Genetics Center, Regeneron Pharmaceuticals Inc
- Niek Verweij
- Regeneron Genetics Center, Regeneron Pharmaceuticals Inc
- Luca A. Lotta
- Regeneron Genetics Center, Regeneron Pharmaceuticals Inc
- DOI
- https://doi.org/10.1038/s41467-022-32398-7
- Journal volume & issue
-
Vol. 13,
no. 1
pp. 1 – 17
Abstract
Fat distribution is associated with cardiometabolic disease, although it has been less well studied than overall obesity. In a multiancestry exome-sequencing study, the authors identified predicted loss-of-function mutations in INHBE associated with favorable fat distribution and protection from type 2 diabetes.